US FDA Moves To Codify Size-Based Threshold For Drugs To Be Deemed Biologics

 
• By Bowman Cox
Insulin Monomer
Insulin, one of the drugs FDA will deem a biologic

More from Biosimilars

More from Biosimilars & Generics